Loading…

Combined Flow‐Fluorescence in situ hybridization to HHV‐8 and EBV reveals the viral heterogeneity of primary effusion lymphoma

Primary effusion lymphoma (PEL) is a rare B‐cell non‐Hodgkin lymphoma associated with Kaposi Sarcoma‐associated herpesvirus (KSHV/HHV8) infection. Lymphoma cells are coinfected with Epstein‐Barr virus (EBV) in 60−80% of cases. Tools allowing a reliable PEL diagnosis are lacking. This study reports P...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical virology 2024-08, Vol.96 (8), p.e29836-n/a
Main Authors: Stammler, Romain, Vacher, Lauriane, Fournier, Benjamin, Lemaire, Pierre, Chauvel, Clémentine, Silvestrini, Marc‐Antoine, Knapp, Silène, Frémont, Grégoire Martin, Meignin, Véronique, Salmona, Maud, Legoff, Jérôme, Vanjak, Anthony, Dunogué, Bertrand, Urbain, Fanny, Lambotte, Olivier, Noël, Nicolas, Gérard, Laurence, Oksenhendler, Eric, Galicier, Lionel, Latour, Sylvain, Boutboul, David
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Primary effusion lymphoma (PEL) is a rare B‐cell non‐Hodgkin lymphoma associated with Kaposi Sarcoma‐associated herpesvirus (KSHV/HHV8) infection. Lymphoma cells are coinfected with Epstein‐Barr virus (EBV) in 60−80% of cases. Tools allowing a reliable PEL diagnosis are lacking. This study reports PEL diagnosis in 4 patients using a Flow‐Fluorescence in situ hybridization (FlowFISH) technique that allowed detection of differentially expressed EBV and HHV8 transcripts within the same sample, revealing viral heterogeneity of the disease. Moreover, infected cells exhibited variable expressions of CD19, CD38, CD40, and CD138. Therefore, FlowFISH is a promising tool to diagnose and characterize complex viral lymphoproliferations.
ISSN:0146-6615
1096-9071
1096-9071
DOI:10.1002/jmv.29836